CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-16 | Tallett Elizabeth E Director | Grant or award | +753 | 7,061 | ||
| 2018-05-16 | Dixon Robert L JR Director | Grant or award | +753 | 10,738 | ||
| 2018-05-16 | SCHAEFER GEORGE A JR Director | Grant or award | +753 | 38,864 | ||
| 2018-05-16 | PERU RAMIRO G Director | Grant or award | +753 | 14,324 | ||
| 2018-05-16 | CLARK R KERRY Director | Grant or award | +753 | 5,809 | ||
| 2018-05-16 | Neri Antonio F Director | Grant or award | +753 | 1,094 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +9,756 | $61.88 | $604K | 25,619 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +7,489 | $146.93 | $1.1M | 33,108 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +14,830 | $89.44 | $1.3M | 47,938 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +4,478 | $152.78 | $684K | 52,416 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +16,232 | $131.80 | $2.1M | 68,648 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise | +6,636 | $166.97 | $1.1M | 75,284 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Sale | −54,497 | $224.32 | $12.2M | 20,787 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Sale | −4,924 | $225.35 | $1.1M | 15,863 |
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −9,756 | 0 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −7,489 | 0 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −14,830 | 0 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −4,478 | 896 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −16,232 | 8,116 | ||
| 2018-05-03 | GRIFFIN BRIAN T EVP & CEO, IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −6,636 | 13,272 |
Page 38 of 40 · 796 trades